Bumrungrad Hospital Public Company Limited
BUGDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $26 | $25 | $21 | $12 |
| % Growth | 1.3% | 22.5% | 66.3% | – |
| Cost of Goods Sold | $13 | $13 | $11 | $8 |
| Gross Profit | $13 | $12 | $10 | $5 |
| % Margin | 51.4% | 49.2% | 46.4% | 38% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3 | $3 | $3 | $3 |
| SG&A Expenses | $4 | $4 | $4 | $3 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $0 |
| Other Operating Expenses | -$0 | -$0 | -$0 | -$0 |
| Operating Expenses | $4 | $4 | $4 | $3 |
| Operating Income | $9 | $8 | $6 | $2 |
| % Margin | 35.6% | 33.5% | 29% | 12.2% |
| Other Income/Exp. Net | $0 | $0 | $0 | -$0 |
| Pre-Tax Income | $9 | $9 | $6 | $1 |
| Tax Expense | $2 | $2 | $1 | $0 |
| Net Income | $8 | $7 | $5 | $1 |
| % Margin | 30.2% | 27.6% | 23.8% | 9.8% |
| EPS | 9.78 | 8.08 | 6.21 | 1.53 |
| % Growth | 21% | 30.1% | 305.9% | – |
| EPS Diluted | 8.96 | 8.08 | 5.69 | 1.4 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $11 | $10 | $7 | $3 |
| % Margin | 40.9% | 38.4% | 34.6% | 22.2% |